Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$209.01 - $232.56 $128,123 - $142,559
-613 Reduced 1.54%
39,149 $233,000
Q4 2023

Jan 18, 2024

BUY
$197.69 - $227.29 $44,282 - $50,912
224 Added 0.57%
39,762 $9.04 Million
Q3 2023

Oct 24, 2023

SELL
$201.05 - $221.7 $6,232 - $6,872
-31 Reduced 0.08%
39,538 $7.95 Million
Q2 2023

Jul 12, 2023

BUY
$211.93 - $241.33 $56,797 - $64,676
268 Added 0.68%
39,569 $9.55 Million
Q1 2023

Apr 14, 2023

SELL
$213.32 - $257.83 $34,344 - $41,510
-161 Reduced 0.41%
39,301 $9.02 Million
Q4 2022

Feb 16, 2023

SELL
$203.72 - $248.97 $29,946 - $36,598
-147 Reduced 0.37%
39,462 $9.29 Million
Q3 2022

Nov 07, 2022

BUY
$204.81 - $262.19 $224,062 - $286,835
1,094 Added 2.84%
39,609 $8.11 Million
Q2 2022

Aug 08, 2022

BUY
$213.86 - $277.87 $87,468 - $113,648
409 Added 1.07%
38,515 $9.03 Million
Q4 2021

Jan 19, 2022

SELL
$271.6 - $314.21 $59,208 - $68,497
-218 Reduced 0.57%
38,106 $12 Million
Q3 2021

Oct 25, 2021

SELL
$274.82 - $308.34 $48,093 - $53,959
-175 Reduced 0.45%
38,324 $10.8 Million
Q2 2021

Jul 26, 2021

SELL
$251.87 - $278.14 $189,406 - $209,161
-752 Reduced 1.92%
38,499 $10.6 Million
Q1 2021

Apr 14, 2021

BUY
$204.88 - $255.03 $223,524 - $278,237
1,091 Added 2.86%
39,251 $10 Million
Q4 2020

Jan 21, 2021

BUY
$186.91 - $214.42 $145,042 - $166,389
776 Added 2.08%
38,160 $7.77 Million
Q3 2020

Oct 28, 2020

SELL
$167.03 - $201.3 $45,098 - $54,351
-270 Reduced 0.72%
37,384 $7.04 Million
Q2 2020

Jul 22, 2020

SELL
$113.31 - $182.44 $1,473 - $2,371
-13 Reduced 0.03%
37,654 $6.26 Million
Q1 2020

Apr 13, 2020

SELL
$104.32 - $195.28 $165,660 - $310,104
-1,588 Reduced 4.05%
37,667 $4.42 Million
Q4 2019

Jan 27, 2020

SELL
$163.48 - $173.61 $11,443 - $12,152
-70 Reduced 0.18%
39,255 $6.64 Million
Q3 2019

Oct 22, 2019

BUY
$159.77 - $178.1 $13,580 - $15,138
85 Added 0.22%
39,325 $6.61 Million
Q2 2019

Jul 22, 2019

BUY
$144.16 - $172.9 $40,941 - $49,103
284 Added 0.73%
39,240 $6.79 Million
Q1 2019

Apr 15, 2019

BUY
$123.7 - $156.3 $1.33 Million - $1.69 Million
10,785 Added 38.28%
38,956 $5.96 Million
Q4 2018

Jan 25, 2019

BUY
$120.82 - $174.09 $30,567 - $44,044
253 Added 0.91%
28,171 $3.56 Million
Q3 2018

Oct 11, 2018

BUY
$167.67 - $188.27 $108,985 - $122,375
650 Added 2.38%
27,918 $4.85 Million
Q2 2018

Jul 23, 2018

SELL
$160.33 - $189.41 $32,867 - $38,829
-205 Reduced 0.75%
27,268 $4.9 Million
Q1 2018

May 02, 2018

BUY
$161.53 - $178.11 $88,518 - $97,604
548 Added 2.04%
27,473 $4.44 Million
Q4 2017

Feb 05, 2018

SELL
$147.99 - $163.95 $2,219 - $2,459
-15 Reduced 0.06%
26,925 $4.3 Million
Q3 2017

Oct 23, 2017

BUY
$149.47 - $160.56 $4.03 Million - $4.33 Million
26,940
26,940 $4.07 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Weybosset Research & Management LLC Portfolio

Follow Weybosset Research & Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weybosset Research & Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weybosset Research & Management LLC with notifications on news.